Levenson J A, Safar M E, Bouthier J E, Benetos A M, Simon A C
Chest. 1983 Feb;83(2 Suppl):325-7. doi: 10.1378/chest.83.2_supplement.325.
Blood pressure, heart rate, and arterial diameter of the brachial artery were studied in patients with sustained essential hypertension before and after administration of three vasodilating drugs: dihydralazine, diltiazem, and dinitrate isosorbide (ISDN). The diameter of the brachial artery was measured using a pulsed Doppler device, enabling the angle between the ultrasound beam and the vessel axis to be evaluated with a precision inferior to 2 percent. The three drugs had similar effects in decreasing the blood pressure and the forearm vascular resistance. Dihydralazine reduced the arterial diameter (p less than 0.001) and increased heart rate. Diltiazem and ISDN increased markedly the arterial diameter (p less than 0.001) but did not change heart rate. Dihydralazine decreased the tangential tension of the arterial wall, while diltiazem and ISDN did not. The study provided evidence that, with vasodilating drugs, the changes in the caliber of peripheral large arteries, which are a determinant of wall arterial tension, can influence the baroreflex-mediated tachycardia caused by use of the drugs.
在持续原发性高血压患者中,研究了三种血管舒张药物(双肼屈嗪、地尔硫䓬和硝酸异山梨酯)给药前后的血压、心率和肱动脉直径。使用脉冲多普勒装置测量肱动脉直径,使超声束与血管轴之间的角度评估精度低于2%。这三种药物在降低血压和前臂血管阻力方面具有相似的效果。双肼屈嗪减小了动脉直径(p<0.001)并增加了心率。地尔硫䓬和硝酸异山梨酯显著增加了动脉直径(p<0.001),但未改变心率。双肼屈嗪降低了动脉壁的切向张力,而地尔硫䓬和硝酸异山梨酯则没有。该研究提供了证据表明,使用血管舒张药物时,作为壁动脉张力决定因素的外周大动脉口径变化可影响药物使用引起的压力反射介导的心动过速。